Cornea/External Disease News

CorneaGen issued product recalls for certain corneal and scleral patch grafts, according to press releases from the FDA.

The first participant has been dosed in the phase 3 registrational COMET-2 study of AR-15512 ophthalmic solution for the treatment of dry eye disease signs and symptoms, according to a press release from Aerie Pharmaceuticals.

Rumors swirled around the exhibit floor and coursed through gatherings of dry eye disease docs who attended the American Society of Cataract and Refractive Surgery meeting.

Kala Pharmaceuticals has entered into a definitive agreement to sell its commercial portfolio and related assets to Alcon, including Eysuvis and Inveltys.

In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting via Zoom, Richard L. Lindstrom, MD, discusses the first prospective trial of netarsudil for the treatment of Fuchs’ dystrophy.

Lirentelimab safely improved severe allergy conjunctivitis and concomitant atopic symptoms, according to a study published in The Journal of Allergy and Clinical Immunology.

DENVER — Patients with infectious keratitis who underwent penetrating keratoplasty earlier in the course of their infection had better postoperative outcomes compared with those who waited longer before having surgery, according to a study.

An algorithm is a set of instructions for solving a problem or accomplishing a task. One common example of an algorithm is a recipe, which consists of specific instructions for preparing a dish or meal.

DESTIN, Fla. — Although not currently curable, the symptoms of Sjögren’s syndrome, like dry eyes and dry mouth, can be effectively managed using a variety of therapies, said a speaker said at the Congress of Clinical Rheumatology East 2022 meeting.

Whoa! That sure happened fast. Did you see that coming? The whole dry eye marketplace turned upside down in — what? — 6 weeks?